Andy Sassine - 15 Aug 2025 Form 4/A - Amendment Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Chief Financial Officer, Director
Signature
/s/ Ilan Katz, attorney-in-fact
Issuer symbol
ARCT
Transactions as of
15 Aug 2025
Net transactions value
+$20,499
Form type
4/A - Amendment
Filing time
20 Aug 2025, 16:01:44 UTC
Date Of Original Report
19 Aug 2025
Previous filing
17 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SASSINE ANDY Chief Financial Officer, Director C/O ARCTURUS THERAPEUTICS HOLDINGS INC., 10628 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO /s/ Ilan Katz, attorney-in-fact 20 Aug 2025 0001515322

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARCT Common Stock Purchase $20,499 +1,238 +0.56% $16.56 221,764 15 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase reported on this Form 4 was effected by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the "ESPP").
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025.